UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1096-1115

2019

Volltextzugriff (PDF)

Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy

European journal of medicinal chemistry, 2018-01, Vol.143, p.656-669

2018

Volltextzugriff (PDF)

The progress and development of GLUT1 inhibitors targeting cancer energy metabolism

Future medicinal chemistry, 2019-09, Vol.11 (17), p.2333-2352

2019

Volltextzugriff (PDF)

DNA framework-engineered chimeras platform enables selectively targeted protein degradation

Nature communications, 2023-07, Vol.14 (1), p.4510-4510, Article 4510

2023

Volltextzugriff (PDF)

Unconventional Passive Enhancement of Transdermal Drug Delivery: toward a Mechanistic Understanding of Penetration Enhancers Releasing from Acrylic Pressure-Sensitive Adhesive of Patches

Pharmaceutical research, 2020-09, Vol.37 (9), p.169-169, Article 169

2020

Volltextzugriff (PDF)

Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer

European journal of medicinal chemistry, 2019-11, Vol.182, p.111629, Article 111629

2019

Volltextzugriff (PDF)

Palladium(II)-Catalyzed Reaction of Lawsones and Propargyl Carbonates: Construction of 2,3-Furanonaphthoquinones and Evaluation as Potential Indoleamine 2,3-Dioxygenase Inhibitors

Journal of organic chemistry, 2018-08, Vol.83 (15), p.8003-8010

2018

Volltextzugriff (PDF)

Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer

Acta pharmaceutica Sinica. B, 2024-02, Vol.14 (2), p.751-764

2024

Volltextzugriff (PDF)

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation

Journal of enzyme inhibition and medicinal chemistry, 2019-01, Vol.34 (1), p.250-263

2019

Volltextzugriff (PDF)

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning

Acta pharmaceutica Sinica. B, 2021-11, Vol.11 (11), p.3678-3682

2021

Volltextzugriff (PDF)

(4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide

MolBank, 2023-06, Vol.2023 (2), p.M1638

2023

Volltextzugriff (PDF)

Bioactive modulators targeting STING adaptor in cGAS-STING pathway

Drug discovery today, 2020-01, Vol.25 (1), p.230-237

2020

Volltextzugriff (PDF)

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

Journal of medicinal chemistry, 2020-11, Vol.63 (22), p.13228-13257

2020

Volltextzugriff (PDF)

Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions

Journal of medicinal chemistry, 2021-09, Vol.64 (18), p.13191-13211

2021

Volltextzugriff (PDF)

Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective

Journal of medicinal chemistry, 2020-12, Vol.63 (24), p.15115-15139

2020

Volltextzugriff (PDF)

A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs

Bioorganic & medicinal chemistry, 2019-03, Vol.27 (5), p.677-685

2019

Volltextzugriff (PDF)

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion

European journal of medicinal chemistry, 2021-02, Vol.211, p.113091-113091, Article 113091

2021

Volltextzugriff (PDF)

Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity

Bioorganic chemistry, 2018-12, Vol.81, p.373-381

2018

Volltextzugriff (PDF)

Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO

Biochemical pharmacology, 2019-10, Vol.168, p.214-223

2019

Volltextzugriff (PDF)

Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor

Biomaterials, 2023-07, Vol.298, p.122133-122133, Article 122133

2023

Volltextzugriff (PDF)

Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery

Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9229-9250

2023

Volltextzugriff (PDF)

Design strategies and recent development of bioactive modulators for glutamine transporters

Drug discovery today, 2024-02, Vol.29 (2), p.103880-103880, Article 103880

2024

Volltextzugriff (PDF)

Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions

European journal of medicinal chemistry, 2024-03, Vol.267, p.116212-116212, Article 116212

2024

Volltextzugriff (PDF)

A critical update on the strategies towards modulators targeting androgen receptors

Bioorganic & medicinal chemistry, 2020-07, Vol.28 (13), p.115554-115554, Article 115554

2020

Volltextzugriff (PDF)

Discovery and development of small molecule modulators targeting glutamine metabolism

European journal of medicinal chemistry, 2019-02, Vol.163, p.215-242

2019

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(106)
Tagungsberichte
(1)

Sprache

Englisch
(105)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(67)
Pharmacology & Pharmacy
(60)
Chemistry, Medicinal
(54)
Humans
(37)
Physical Sciences
(31)
Chemistry
(29)
Chemistry, Organic
(20)
Cell Line, Tumor
(17)
Antineoplastic Agents - Pharmacology
(16)
Animals
(14)
Antineoplastic Agents - Chemistry
(14)
Antitumor
(12)
Structure-Activity Relationship
(12)
Biochemistry & Molecular Biology
(11)
Antineoplastic Agents - Chemical Synthesis
(10)
Drug Discovery
(9)
Drug Screening Assays, Antitumor
(9)
Molecular Docking Simulation
(9)
Mice
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy

The progress and development of GLUT1 inhibitors targeting cancer energy metabolism

DNA framework-engineered chimeras platform enables selectively targeted protein degradation

Unconventional Passive Enhancement of Transdermal Drug Delivery: toward a Mechanistic Understanding of Penetration Enhancers Releasing from Acrylic Pressure-Sensitive Adhesive of Patches

Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer

Palladium(II)-Catalyzed Reaction of Lawsones and Propargyl Carbonates: Construction of 2,3-Furanonaphthoquinones and Evaluation as Potential Indoleamine 2,3-Dioxygenase Inhibitors

Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning

(4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide

Bioactive modulators targeting STING adaptor in cGAS-STING pathway

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions

Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective

A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion

Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity

Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO

Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor

Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery

Design strategies and recent development of bioactive modulators for glutamine transporters

Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions

A critical update on the strategies towards modulators targeting androgen receptors

Discovery and development of small molecule modulators targeting glutamine metabolism

Suchergebnisse filtern